Further analysis showed that there was no significant change in the number of classical monocytes (CD14++16−) in the COVID‐19 patients compared to healthy controls; however, an increase in the intermediate (CD14++16+) and nonclassical (CD14+CD16++) subsets were observed (Figure 2A,B). The gene discussed is CD14; the disease is COVID-19.